Trials / Completed
CompletedNCT04528407
BS-FU01 Follow-Up Study of FluBHPVE6E7 Study Subjects
Follow-up Study for Patients Having Received FluBHPVE6E7 in Clinical Studies
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (actual)
- Sponsor
- BlueSky Immunotherapies GmbH · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
This is a follow-up study for patients treated with FluBHPVE6E7 in previous interventional studies.
Detailed description
BS-FU01 is a follow-up study for patients treated with FluBHPVE6E7 in previous phase 1 and 2 interventional studies. The aim of the follow-up study is to assess the safety and immunogenicity of FluBHPVE6E7, changes in the HPV infection status, cervical cytology, and biodistribution after treatment with FluBHPVE6E7 in previous studies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observation without intervention | This study is a follow-up study without intervention. |
Timeline
- Start date
- 2021-04-09
- Primary completion
- 2025-01-31
- Completion
- 2025-01-31
- First posted
- 2020-08-27
- Last updated
- 2025-02-13
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT04528407. Inclusion in this directory is not an endorsement.